Merck KGaA (FRA:MRK) received a €101.00 ($108.60) price objective from equities research analysts at Berenberg Bank in a research note issued on Tuesday. The firm currently has a “neutral” rating on the stock.

Other research analysts also recently issued research reports about the stock. Deutsche Bank AG set a €110.00 ($118.28) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a report on Thursday, July 28th. Morgan Stanley set a €103.00 ($110.75) price objective on shares of Merck KGaA and gave the stock a “neutral” rating in a report on Monday, August 1st. Warburg Research set a €103.10 ($110.86) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a report on Thursday, August 4th. DZ Bank AG restated a “buy” rating on shares of Merck KGaA in a report on Friday, August 5th. Finally, equinet AG set a €85.00 ($91.40) price objective on shares of Merck KGaA and gave the stock a “buy” rating in a report on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of €101.91 ($109.58).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Shares of Merck KGaA (FRA:MRK) opened at 94.336 on Tuesday. The firm has a market cap of €41.06 billion and a PE ratio of 27.592. The stock’s 50 day moving average is €95.49 and its 200-day moving average is €93.27. Merck KGaA has a 1-year low of €70.87 and a 1-year high of €100.00.

About Merck KGaA

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.